ETON

Eton Pharmaceuticals Inc

50.00

Oct 23 • 3:59 PM ET -0.02 (-0.04%)

49.44

Aftermarket • 7:30 PM ET -0.56 (-1.12%)

Healthcare Drug Manufacturers - Specialty & Generic USA Small NASD

Peers: XERS NBIX ANIP HROW ZVRA TVTX HRMY ASND RYTM SPRB

| Held by: VTI IWM VXF IWO FYC VTWO XPH SCHA FYX IWC

Scroll to Statements

Index	RUT
Market Cap	1.43B
Enterprise Value	1.43B
Income	12.69M
Sales	105.59M
Book/sh	1.65
Cash/sh	0.94
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	44
IPO	Nov 13, 2018

P/E	132.21
Forward P/E	23.99
PEG	0.22
P/S	13.53
P/B	30.36
P/C	53.24
P/FCF	97.01
EV/EBITDA	68.00
EV/Sales	13.56
Quick Ratio	1.30
Current Ratio	1.52
Debt/Eq	0.63
LT Debt/Eq	0.43
Option/Short	Yes / Yes

EPS (ttm)	0.38
EPS next Y	2.08
EPS next Q	0.31
EPS this Y	210.54%
EPS next Y	91.79%
EPS next 5Y	107.84%
EPS past 3/5Y	21.89% 33.66%
Sales past 3/5Y	55.53% 359.57%
EPS Y/Y TTM	399.54%
Sales Y/Y TTM	81.49%
EPS Q/Q	467.43%
Sales Q/Q	98.59%
Earnings	Aug 13 AMC
EPS/Sales Surpr.	84.40% 38.67%

Insider Own	4.93%
Insider Trans	-30.01%
Inst Own	69.94%
Inst Trans	10.66%
ROA	11.67%
ROE	35.97%
ROIC	19.01%
Gross Margin	57.87%
Oper. Margin	15.63%
Profit Margin	12.02%
SMA20	-6.04%
SMA50	-12.18%
SMA200	43.65%
Trades

Shs Outstand	28.29M
Shs Float	27.17M
Short Float	6.75%
Short Ratio	3.14
Short Interest	1.83M
52W High	66.37 -24.66%
52W Low	14.27 250.39%
Volatility	4.35% 6.07%
ATR (14)	2.84
RSI (14)	39.07
Beta	0.89
Rel Volume	0.54
Avg Volume	583.32K
Volume	314,809

Perf Week	-0.62%
Perf Month	-15.95%
Perf Quarter	18.18%
Perf Half Y	117.20%
Perf YTD	195.68%
Perf Year	169.69%
Perf 3Y	1191.99%
Perf 5Y	807.44%
Perf 10Y	-
Recom	1.00
Target Price	71.50
Prev Close	50.02
Price	50.00
Change %	-0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-17-26	Initiated	Canaccord Genuity	Buy	$60
Jan-23-25	Reiterated	H.C. Wainwright	Buy	$17 → $33
Jan-10-25	Initiated	B. Riley Securities	Buy	$21
Jan-06-25	Reiterated	H.C. Wainwright	Buy	$15 → $17
Sep-04-24	Resumed	H.C. Wainwright	Buy	$9
May-06-24	Initiated	Craig Hallum	Buy	$8
Oct-14-21	Resumed	B. Riley Securities	Buy	$10
Jan-04-21	Reiterated	H.C. Wainwright	Buy	$20 → $15
Sep-20-19	Initiated	B. Riley FBR	Buy	$13.50
Jun-10-19	Initiated	H.C. Wainwright	Buy	$15

Oct-14-26 06:50AM	Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT (diazepam) Buccal Film (GlobeNewswire)
Sep-28-26 06:50AM	Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO (miltefosine) Capsules (GlobeNewswire)
Aug-27-26 06:50AM	Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-21-26 12:14PM	Three Biotech Stocks Stick Out With Their Stellar Charts (Investor's Business Daily) +5.94%
Aug-14-26 01:30PM	This Analyst Believes Eton Pharmas Raised Guidance Is Conservative ETON Stock Heads For Best Ever Day (Stocktwits) +44.26%
01:02AM	Loading…
01:02AM	Eton Pharmaceuticals Inc (ETON) (Q2 2026) Earnings Call Highlights: Record Revenue and ... (GuruFocus.com)
Aug-13-26 04:05PM	Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-12-26 09:23AM	Earnings To Watch: Eton Pharmaceuticals Inc (ETON) Q2 2026 -- GF Value Sees 27% Downside (GuruFocus.com)
Aug-05-26 06:50AM	Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 (GlobeNewswire)
Aug-03-26 06:50AM	Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 (GlobeNewswire)
Jul-29-26 06:50AM	Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI (hydrocortisone) Oral Solution (GlobeNewswire)
Jul-28-26 12:46PM	ETON Stock Jumps 10%: Why Does This Analyst See 47% Upside To Stock? (Stocktwits) +10.28%
Jul-17-26 09:41AM	Apple upgraded, Brinker initiated: Wall Street's top analyst calls (The Fly) +13.79%
May-19-26 04:30PM	Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO (miltefosine) (GlobeNewswire)
May-15-26 01:02AM	Eton Pharmaceuticals Inc (ETON) Q1 2026 Earnings Call Highlights: Record Sales and Strategic ... (GuruFocus.com)
04:05PM	Loading…
May-14-26 04:05PM	Eton Pharmaceuticals Reports First Quarter 2026 Financial Results (GlobeNewswire)
May-12-26 04:30PM	Eton Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-04-26 04:30PM	Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 (GlobeNewswire)
May-01-26 06:50AM	Eton Pharmaceuticals relaunches HEMANGEOL (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution (GlobeNewswire) +19.82%
Apr-27-26 06:50AM	Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 (GlobeNewswire)
Apr-16-26 06:50AM	Eton Pharmaceuticals Announces CFO Succession Plan (GlobeNewswire) -9.42%
Mar-19-26 11:01PM	Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +9.20% +7.46%
04:05PM	Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-03-26 04:30PM	Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026 (GlobeNewswire)
Mar-02-26 07:27AM	Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL (propranolol hydrochloride) Oral Solution (GlobeNewswire) +6.83%
Feb-25-26 01:47PM	Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution (GlobeNewswire)
Feb-20-26 06:50AM	Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th (GlobeNewswire)
Feb-02-26 06:50AM	Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate (GlobeNewswire)
Dec-04-25 03:28PM	Implied Volatility Surging for Eton Pharmaceuticals Stock Options (Zacks)
Nov-24-25 04:30PM	Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th (GlobeNewswire)
04:30PM	Loading…
Nov-12-25 04:30PM	Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th (GlobeNewswire)
Nov-06-25 05:35PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -11.70%
04:05PM	Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-05-25 07:49AM	Eton Pharmaceuticals Inc (ETON) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-23-25 04:30PM	Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 (GlobeNewswire)
Sep-22-25 12:57PM	Implied Volatility Surging for Eton Pharmaceuticals Stock Options (Zacks)
Aug-20-25 06:50AM	Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-07-25 06:10PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +12.32%
04:05PM	Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-31-25 10:00AM	Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-28-25 07:00AM	Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 (GlobeNewswire)
Jul-11-25 10:05AM	Adrenal Crisis Market Analysis and Forecast Report 2025-2035 with Competitive Benchmarking of Eton Pharmaceuticals, Antares Pharma, and Pfizer (GlobeNewswire) -6.88%
Jul-08-25 06:50AM	Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) (GlobeNewswire) +9.80%
Jun-27-25 06:50AM	Eton Pharmaceuticals Announces Addition to Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
Jun-02-25 12:00PM	Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why (Zacks)
08:50AM	Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-29-25 07:12AM	FDA approves Etons application for hydrocortisone oral solution (Pharmaceutical Technology) -5.78%
May-28-25 11:49PM	Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency (Insider Monkey)
05:28PM	Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI (hydrocortisone) Oral Solution (GlobeNewswire)
May-14-25 04:30PM	Eton Pharmaceuticals to Participate at Upcoming Investor Conferences (GlobeNewswire) +15.07%
09:19AM	Q1 2025 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
03:17AM	Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ... (GuruFocus.com)
May-13-25 05:15PM	Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-12-25 09:32AM	Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
May-08-25 05:45PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 10:00AM	Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline (Zacks)
May-01-25 04:30PM	Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 (GlobeNewswire)
10:01AM	Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release (Zacks)
Apr-28-25 06:50AM	Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) (GlobeNewswire)
Apr-01-25 07:00AM	Eton Pharmaceuticals Out-Licenses International Rights to Increlex (GlobeNewswire)
Mar-21-25 10:56PM	Eton Pharmaceuticals Inc (ETON) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-18-25 08:00AM	Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:50AM	Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
Mar-14-25 06:50AM	Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 (GlobeNewswire) +6.71%
Mar-04-25 06:50AM	Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 (GlobeNewswire)
Mar-03-25 06:50AM	Eton Pharmaceuticals Announces Commercial Launch of Galzin (zinc acetate) Capsules (GlobeNewswire)
Feb-10-25 07:11AM	Eton secures US patent for diabetes insipidus treatment (Pharmaceutical Technology)
Feb-07-25 06:50AM	Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 (GlobeNewswire)
Feb-06-25 06:50AM	Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 (GlobeNewswire)
Jan-25-25 09:15AM	Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum (TipRanks)
Jan-24-25 04:17AM	Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? (Zacks)
Jan-15-25 01:46PM	Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey) +6.56%
Jan-03-25 06:50AM	Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin (GlobeNewswire) -9.15%
Dec-20-24 06:50AM	Eton Pharmaceuticals Closes Acquisition of Increlex (mecasermin injection) (GlobeNewswire)
Dec-17-24 06:50AM	Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial (GlobeNewswire)
Dec-03-24 06:50AM	Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer (GlobeNewswire) -5.14%
Nov-26-24 09:48AM	Eton acquires US rights to neonatal diabetes treatment from AMMTeK (Pharmaceutical Technology)
06:55AM	Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK (TipRanks)
Nov-25-24 06:50AM	Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) (GlobeNewswire) +7.12%
Nov-13-24 07:09AM	Q3 2024 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +15.59%
02:18AM	Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... (GuruFocus.com)
Nov-12-24 04:01PM	Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results (GlobeNewswire) -5.56%
Nov-11-24 07:18AM	What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings (GuruFocus.com) +10.59%
Nov-07-24 07:00AM	Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) (GlobeNewswire)
Nov-06-24 04:30PM	Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 (GlobeNewswire)
Oct-29-24 09:30AM	Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum (TipRanks)
Oct-28-24 11:01AM	Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc. (GuruFocus.com)
Oct-17-24 04:15PM	SWK Holdings Provides Portfolio Update (ACCESSWIRE)
Oct-09-24 01:02AM	Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares (GuruFocus.com)
Oct-03-24 06:30AM	Eton Pharmaceuticals, Inc to Acquire Increlex (mecasermin injection) from Ipsen (GlobeNewswire) +16.33%
Sep-13-24 02:22AM	Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc. (GuruFocus.com) +6.85%
Aug-22-24 04:30PM	Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) +6.82%
Aug-08-24 09:59PM	ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:01PM	Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-30-24 05:30PM	Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-17-24 04:15PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (ACCESSWIRE)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Krempa David	Chief Business Officer	Oct 06 '26	Sale	55.07	4,166	229,406	43,381	Oct 06 04:49 PM
Krempa David	Officer	Oct 06 '26	Proposed Sale	55.07	4,166	229,406		Oct 06 04:05 PM
MAIER PAUL V	Director	Aug 28 '26	Option Exercise	3.78	50,000	189,000	109,745	Aug 28 04:51 PM
MAIER PAUL V	Director	Aug 28 '26	Sale	59.07	50,000	2,953,572	59,745	Aug 28 04:51 PM
MAIER PAUL V	Director	Aug 28 '26	Proposed Sale	59.07	50,000	2,953,530		Aug 28 04:41 PM
Krempa David	Chief Business Officer	Aug 24 '26	Option Exercise	7.31	25,000	182,750	62,025	Aug 24 05:19 PM
Krempa David	Chief Business Officer	Aug 24 '26	Sale	65.07	25,000	1,626,750	37,025	Aug 24 05:19 PM
Krempa David	Officer	Aug 24 '26	Proposed Sale	65.07	25,000	1,626,750		Aug 24 04:19 PM
BRYNJELSEN SEAN	President & CEO	Aug 20 '26	Sale	60.70	91,022	5,525,301	961,194	Aug 20 06:26 PM
BRYNJELSEN SEAN	President & CEO	Aug 19 '26	Sale	62.65	8,978	562,472	1,052,216	Aug 20 06:26 PM
BRYNJELSEN SEAN	Director	Aug 19 '26	Proposed Sale	63.43	100,000	6,343,000		Aug 19 10:49 AM
Opaleye Management Inc.	10% Owner	Jul 14 '26	Sale	37.54	28,315	1,063,033	40,000	Jul 16 05:14 PM
BRYNJELSEN SEAN	President & CEO	Jul 14 '26	Option Exercise	1.37	200,000	274,000	1,061,194	Jul 14 05:28 PM
Opaleye Management Inc.	10% Owner	Jul 02 '26	Sale	37.39	90,000	3,364,659	60,000	Jul 07 06:29 PM
Opaleye Management Inc.	10% Owner	Jul 07 '26	Sale	38.37	26,685	1,023,978	53,315	Jul 07 06:29 PM
Opaleye Management Inc.	10% Owner	Jul 06 '26	Sale	38.00	10,000	380,000	2,700,000	Jul 07 06:29 PM
Gruber James R.	Officer	Jun 26 '26	Proposed Sale	35.70	251,818	8,990,000		Jun 26 04:14 PM
Gruber James R.	Officer	Jun 25 '26	Proposed Sale	35.01	25,000	875,251		Jun 25 04:12 PM
Gruber James R.	Officer	Jun 23 '26	Proposed Sale	33.23	25,000	830,874		Jun 23 04:32 PM
Adams Jennifer McKie	Director	Jun 17 '26	Option Exercise	3.78	50,000	189,000	50,000	Jun 17 05:08 PM
Adams Jennifer McKie	Director	Jun 17 '26	Sale	32.48	50,000	1,623,795	0	Jun 17 05:08 PM
Adams Jennifer McKie	Director	Jun 17 '26	Proposed Sale	32.37	50,000	1,618,500		Jun 17 11:43 AM
Gruber James R.	Officer	Jun 02 '26	Proposed Sale	27.00	3,117	84,163		Jun 02 04:48 PM
BRYNJELSEN SEAN	President & CEO	May 28 '26	Sale	31.88	120,000	3,825,717	833,694	May 29 04:16 PM
BRYNJELSEN SEAN	Director	May 28 '26	Proposed Sale	32.40	120,000	3,888,000		May 28 03:12 PM
Krempa David	Chief Business Officer	May 22 '26	Option Exercise	3.58	30,591	109,516	68,046	May 27 06:28 PM
Krempa David	Chief Business Officer	May 26 '26	Option Exercise	1.38	37,524	51,658	62,773	May 27 06:28 PM
Krempa David	Chief Business Officer	May 27 '26	Option Exercise	2.18	19,679	42,879	44,928	May 27 06:28 PM
Krempa David	Chief Business Officer	May 22 '26	Sale	33.39	42,797	1,428,816	25,249	May 27 06:28 PM
Krempa David	Chief Business Officer	May 26 '26	Sale	31.49	37,524	1,181,732	25,249	May 27 06:28 PM
Krempa David	Chief Business Officer	May 27 '26	Sale	31.47	19,679	619,375	25,249	May 27 06:28 PM
Krempa David	Officer	May 22 '26	Proposed Sale	35.00	100,000	3,500,000		May 22 04:24 PM
RIEDEL NORBERT G	Director	Apr 21 '26	Option Exercise	8.10	32,155	260,605	67,155	Apr 22 04:40 PM
Krempa David	Officer	Jan 14 '26	Proposed Sale	15.62	1,942	30,334		Jan 14 05:17 PM
Gruber James R.	Officer	Jan 14 '26	Proposed Sale	15.47	2,293	35,484		Jan 14 05:09 PM
BRYNJELSEN SEAN	Officer	Jan 14 '26	Proposed Sale	15.39	5,015	77,182		Jan 14 11:28 AM
Gruber James R.	Officer	Dec 12 '25	Proposed Sale	16.88	5,450	91,996		Dec 12 05:11 PM
BRYNJELSEN SEAN	Officer	Dec 12 '25	Proposed Sale	16.88	8,035	135,631		Dec 12 05:05 PM
Erdogan-Trinkaus Ipek	Officer	Dec 12 '25	Proposed Sale	16.91	99	1,674		Dec 12 04:50 PM
Krempa David	Officer	Dec 12 '25	Proposed Sale	16.88	7,545	127,360		Dec 12 04:46 PM

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

PresidentMr. Sean E. Brynjelsen

Chief Business OfficerMr. David C. Krempa

ConsultantMr. James R. Gruber CPA

Chief Commercial OfficerMs. Ipek Erdogan-Trinkaus

Chief Financial Officer & SecretaryMs. Judith M. Matthews

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ETON

Eton Pharmaceuticals Inc

Upgrade your Finviz experience